Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gefitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01861223
What this trial is testing

Afatinib Plus Nimotuzumb for NSCLC

Who this might be right for
NSCLC
Samsung Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT00255476
What this trial is testing

The IRESSA Novel Head and Neck Chemotherapy Evaluation Study

Who this might be right for
Squamous Cell CancerCancer of Head and Neck
AstraZeneca 64
Large-scale testing (Phase 3)UnknownNCT02824458
What this trial is testing

Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations

Who this might be right for
EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors
Sun Yat-sen University 246
Testing effectiveness (Phase 2)Study completedNCT00052169
What this trial is testing

Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
NSABP Foundation Inc 33
Large-scale testing (Phase 3)Study completedNCT00635973
What this trial is testing

Open-Label Extension of Other SZ1839 (Iressa) Trials

Who this might be right for
Cancer
AstraZeneca 100
Testing effectiveness (Phase 2)Study completedNCT00242762
What this trial is testing

ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer

Who this might be right for
Head and Neck Cancer
AstraZeneca 36
Testing effectiveness (Phase 2)Study completedNCT00242788
What this trial is testing

IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure

Who this might be right for
Colorectal Cancer
AstraZeneca 40
Testing effectiveness (Phase 2)UnknownNCT02930954
What this trial is testing

Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance

Who this might be right for
Non-small-cell Lung Cancer
Caicun Zhou 180
Testing effectiveness (Phase 2)Study completedNCT00238251
What this trial is testing

Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases

Who this might be right for
Lung CancerMetastatic Cancer
Swiss Cancer Institute 59
Testing effectiveness (Phase 2)Study completedNCT00352105
What this trial is testing

Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
David Adelstein 60
Large-scale testing (Phase 3)Study completedNCT00034879
What this trial is testing

Iressa Expanded Access Program (EAP)

Who this might be right for
CarcinomaNon-small-cell LungMetastases+1 more
AstraZeneca
Early research (Phase 1)Study completedNCT02157883
What this trial is testing

Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)

Who this might be right for
Advanced Non Small Cell Lung CancerAdvanced (Inoperable) Non Small Cell Lung Cancer
AstraZeneca 39
Testing effectiveness (Phase 2)Study completedNCT00824746
What this trial is testing

Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Chonnam National University Hospital 23
Testing effectiveness (Phase 2)Study completedNCT00042991
What this trial is testing

Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas

Who this might be right for
Untreated Childhood Anaplastic AstrocytomaUntreated Childhood Anaplastic OligodendrogliomaUntreated Childhood Brain Stem Glioma+5 more
National Cancer Institute (NCI) 69
Large-scale testing (Phase 3)UnknownNCT02416739
What this trial is testing

Anticancer Activity of Nicotinamide on Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
Il Yeong Park, Ph.D. 110
Testing effectiveness (Phase 2)Study completedNCT00086957
What this trial is testing

Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 31
Large-scale testing (Phase 3)UnknownNCT03381066
What this trial is testing

A Phase III, Randomized, Multi-center Study to Determine the Efficacy of the Intercalating Combination Treatment of Chemotherapy and Gefitinib or Chemotherapy as Adjuvant Treatment in NSCLC With Common EGFR Mutations.

Who this might be right for
Completely Resected NSCLC With Common EGFR Mutations
Yonsei University 225
Not applicableApproved For MarketingNCT00683306
What this trial is testing

Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further Treatment

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
AstraZeneca
Testing effectiveness (Phase 2)Study completedNCT00188617
What this trial is testing

Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC

Who this might be right for
LUNG CANCER
University Health Network, Toronto 35
Large-scale testing (Phase 3)Study completedNCT01769066
What this trial is testing

Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC

Who this might be right for
NSCLC
Fudan University 117
Next Page